Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 5/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.44 |
| ▸ | PKM | P14618 | 3/20 | 0.44 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbic Acid SCHEMBL27542402 | 1.00 | CA1 (0.44) | CA1CA2CA4CA12CA3 | |
| Sorbic Acid SCHEMBL27148 | 1.00 | CA1 (0.44) | CA1CA2CA4CA12CA3 | |
| Sorbic Acid SCHEMBL5954164 | 0.87 | ESR1 (0.35) | CA1CA2CA4CA12CA3 | |
| Phenol SCHEMBL28943818 | 0.85 | CA1 (0.50) | CA1CA2CA4CA12CA3 | |
| Sorbic Acid SCHEMBL8580923 | 0.85 | TSHR (0.42) | TDP1HCAR2ALDH1A1HDAC3TNKS | |
| Sorbic Acid SCHEMBL8580921 | 0.85 | TSHR (0.42) | TDP1HCAR2ALDH1A1HDAC3TNKS | |
| Biphenyl SCHEMBL27698809 | 0.84 | MAPT (0.44) | CA1CA2CA4HCAR2MAPT | |
| Sorbic Acid SCHEMBL8205949 | 0.84 | GAA (0.44) | CA1CA2CA4HCAR2MAPT | |
| Sorbic Acid SCHEMBL28418596 | 0.84 | GAA (0.44) | CA1CA2CA4HCAR2MAPT | |
| Paraben SCHEMBL29018816 | 0.83 | CA2 (0.57) | CA1CA2CA4CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16025 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230014425-A1 | PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION | Hikma Pharmaceuticals International Limited | 2023-01-19 | — | — | US | claimed |
| US-20220023201-A1 | PHENYLEPHRINE HYDROCHLORIDE READY-TO-USE SOLUTION | HIKMA PHARMACEUTICALS USA INC. | 2022-01-27 | — | — | US | claimed |
| EP-3474849-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | The Broad Institute, Inc. (US) | 2019-05-01 | — | — | EP | claimed |
| EP-3137488-B1 | PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CELL-TARGETING MOLECULES COMPRISING THE SAME | MOLECULAR TEMPLATES INC (US) | 2019-01-02 | — | — | EP | claimed |
| US-9962369-B2 | Methods and compositions for transdermal delivery | SPRAYABLE HOLDINGS, INC. (US) | 2018-05-08 | — | — | US | claimed |
| US-9949952-B2 | Methods and compositions for transdermal delivery | SPRAYABLE HOLDINGS, INC. (US) | 2018-04-24 | — | — | US | claimed |
| WO-2018005445-A1 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DIABETES | THE BROAD INSTITUTE, INC. (US) | 2018-01-04 | — | — | WO | claimed |
| CN-106572986-A | Methods and compositions for transdermal delivery | 本杰明·M·余 | 2017-04-19 | — | — | CN | claimed |
| EP-3116489-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY | Yu, Benjamin M. (US) | 2017-01-18 | — | — | EP | claimed |
| US-20160317435-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS | SPRAYABLE HOLDINGS, INC. | 2016-11-03 | — | — | US | claimed |
| WO-2014138708-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORMS OF SOLUTION OR SUSPENSION | YU BENJAMIN M (US) | 2014-09-12 | — | — | WO | claimed |
| US-20140256749-A1 | METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF CAFFEINE IN THE FORM OF SOLUTIONS OR SUSPENSIONS | SPRAYABLE HOLDINGS, INC. | 2014-09-11 | — | — | US | claimed |
| EP-1711207-A4 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX INC (US) | 2008-05-07 | — | — | EP | claimed |
| EP-1761554-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | Biosource Pharm, Inc. (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1212422-B1 | HUMAN CTLA-4 ANTIBODIES AND THEIR USES | MEDAREX INC (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1711207-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | Medarex, Inc. (US) | 2006-10-18 | — | — | EP | claimed |
| WO-2006083317-A2 | PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME | BIOSOURCE PHARM, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| WO-2005059106-A2 | INTERFERON ALPHA ANTIBODIES AND THEIR USES | MEDAREX, INC. (US) | 2005-06-30 | — | — | WO | claimed |
| EP-1295130-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2001070776-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2001-09-27 | — | — | WO | claimed |